Findings from a new study on the efficacy of the advanced radioactive tracer Fluciclovine in radiation treatment have revealed that it significantly improves the chance of patient survival without the reoccurrence of cancer. This conclusion came after 75.5 percent of patients who had recurrent prostate cancer and were imaged with the radiotracer survived for three

Researchers tested Cerenkov luminescence imaging (CLI) in 10 high-risk prostate cancer patients, and they detected a residual tumor. The researchers were from the University Medical Center Essen in Germany. CLI can now be used for identifying cancerous cells during prostate cancer surgery. When surgeons miss cancerous cells during surgery, it increases the chances of reoccurrence

A positron emission tomography (PET-CT) is used to scan for cancer and to know more about its current stage.  A PET-CT scan is more specific than other imaging options. Doctors use it to check if the cancer treatment is working, plan for radiotherapy, and find the exact position for a biopsy. After your cancer treatment,

Positron Emission Tomography (PET) is an imaging method that works by tracking sugar uptake in both healthy and abnormal cells in the body. It enables radiologists to see body function (cell activity) and identify areas that are absorbing sugar. To determine the tissues that absorb high amounts of sugar, the patient is injected with a

The total body dynamic PET scans could be used to detect metastatic cancer successfully. Dynamic PET provides parametric images showing the actual behavior of the tissue. The parametric images can potentially help to detect lesions and evaluate the response of cancer to therapy.But this potential has not been within the clinic, as conventional PET scanners don’t